Search

Clinical guidance: using the NAL-NL3 Fitting System in practice

NAL-NL3 modernises hearing aid prescription with modular, evidence-based modules, improving real-world comfort and communication for diverse listening needs. Hearing aid prescription has long relied on a single, audiogram-based formula to guide amplification. While this approach has delivered reliable outcomes for...

Lawrence Werth (19 October 1956 – 19 August 2014)

In August the audiology community was saddened to learn that Lawrence Werth (57), Chairman of PC Werth Ltd, London had passed away after a brave battle with skin cancer. A prolific contributor to this magazine over the years, he is...

Redeployment of audiologists during COVID-19

As the demand on intensive therapy units in the NHS increased, volunteers from the audiology profession stepped in to support colleagues. Here, they share their experiences of caring on the frontline. Redefining normal: from outpatients to the ICU By Emilee...

Changing perceptions in head and neck cancer management caused by quality of life issues

Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...